What is the proper use and administration of Human Chorionic Gonadotropin (HCG) in medical treatments?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Human Chorionic Gonadotropin (HCG) should be used under the guidance of a healthcare provider for specific medical conditions, including fertility treatments and hormonal disorders, with careful consideration of its potential side effects and proper administration.

Proper Use and Administration

For fertility treatment in women, HCG is typically administered as an injection of 5,000-10,000 IU given to trigger ovulation after follicular development has been stimulated with other medications 1. In men with hypogonadism, HCG is used at doses of 1,000-2,000 IU administered subcutaneously 2-3 times weekly to stimulate testosterone production 1. For prepubertal boys with cryptorchidism (undescended testicles), a common regimen is 500-1,000 IU administered 2-3 times weekly for 2-6 weeks.

Key Considerations

  • HCG must be prescribed by a healthcare provider and is administered via subcutaneous or intramuscular injection.
  • The medication requires proper storage (usually refrigeration) and careful handling.
  • Side effects may include headache, irritability, restlessness, depression, fatigue, edema, pain at injection site, and in rare cases, ovarian hyperstimulation syndrome in women.
  • HCG works by mimicking luteinizing hormone (LH), which stimulates the production of testosterone in men and triggers ovulation in women.
  • It should not be used for weight loss despite some off-label promotion for this purpose, as this application is not FDA-approved and lacks scientific support.

Fertility Treatment Timing

In the context of fertility treatments, the timing of HCG administration is crucial. For instance, in intrauterine insemination (IUI) stimulated with gonadotrophins, single IUI can be performed any time between 24 and 40 hours after HCG injection without compromising pregnancy rates 1. This highlights the importance of precise timing in fertility treatments to maximize the chances of successful pregnancy.

Hormonal Disorders

For men with idiopathic hypogonadotropic hypogonadism (IHH), HCG is often the first-line treatment to restore testosterone production and spermatogenesis, with initial treatment involving HCG injections followed by FSH injections when indicated 1. This approach underscores the role of HCG in managing specific hormonal disorders, particularly in cases where testosterone production needs to be stimulated.

Conclusion is not allowed, so the response ends here.

From the FDA Drug Label

PRECAUTIONS: General Induction of androgen secretion by HCG may induce precocious puberty in patients treated for cryptorchidism. Therapy should be discontinued if signs of precocious puberty occur. Since androgens may cause fluid retention, HCG should be used with caution in patients with cardiac or renal disease, epilepsy, migraine or asthma WARNINGS: HCG should be used in conjunction with human menopausal gonadotropins only by physicians experienced with infertility problems who are familiar with the criteria for patient selection, contraindications, warnings, precautions and adverse reactions described in the package insert for menotropins.

The proper use and administration of Human Chorionic Gonadotropin (HCG) in medical treatments should be done with caution.

  • HCG should be used by physicians experienced with infertility problems.
  • It should be used in conjunction with human menopausal gonadotropins only by physicians familiar with the criteria for patient selection, contraindications, warnings, precautions, and adverse reactions.
  • Therapy should be discontinued if signs of precocious puberty occur.
  • HCG should be used with caution in patients with cardiac or renal disease, epilepsy, migraine, or asthma 2 2. Key warnings include:
  • Ovarian hyperstimulation
  • Rupture of ovarian cysts
  • Multiple births
  • Arterial thromboembolism
  • Anaphylaxis and other hypersensitivity reactions 2.

From the Research

Proper Use and Administration of HCG

The proper use and administration of Human Chorionic Gonadotropin (HCG) in medical treatments is crucial to prevent complications such as ovarian hyperstimulation syndrome (OHSS).

  • HCG is commonly used in fertility treatments, such as in vitro fertilization (IVF) and ovulation induction, to stimulate ovulation and support pregnancy 3, 4.
  • The administration of HCG should be carefully monitored to prevent OHSS, which can be severe and life-threatening 4, 5.
  • The risk of OHSS can be minimized by using appropriate doses of HCG and carefully selecting patients for treatment 4.

Prevention and Management of OHSS

Prevention and management of OHSS are critical to ensure patient safety.

  • Methods to prevent OHSS include careful patient selection, dose adjustment of HCG, and the use of alternative medications 4.
  • Management of OHSS involves hospitalization, fluid and electrolyte management, and abdominal paracentesis in severe cases 4, 5.
  • In cases of severe OHSS, serial serum beta-hCG and transvaginal ultrasound follow-up may be necessary to detect potential ectopic pregnancies 5.

Diagnosis and Monitoring of Pregnancy

HCG plays a crucial role in the diagnosis and monitoring of pregnancy.

  • HCG can be measured quantitatively in serum or urine to diagnose pregnancy and monitor its progression 6.
  • The measurement of HCG can also be useful in detecting pregnancy-related disorders and gynecological cancers 6.
  • However, the diagnosis of pregnancy should be confirmed using a combination of clinical and laboratory tests, including ultrasound and beta-hCG measurements 3, 5.

Rare Complications of HCG Administration

Rare complications of HCG administration can occur, including late-onset OHSS and thyrotoxicosis.

  • Late-onset OHSS can occur in patients with ectopic pregnancies or molar pregnancies, and can be caused by high levels of endogenous HCG 3, 7.
  • Thyrotoxicosis can occur in patients with molar pregnancies, and can be caused by high levels of HCG stimulating the thyroid gland 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.